Oxford Biotherapeutics is a clinical-stage biotechnology company focusing on the development of antibody therapeutics for the treatment of cancer. OBT’s OGAP-verify® platform is the world's largest, cancer specific, membrane protein library, directly measuring plasma membrane protein expression in patient tumors. OGAP is used to identify novel, highly tumor specific antigens for novel first-in-class ADC, T-cell Engager (TCE) and Chimeric Antigen Receptor (CAR-T) targets. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. Our clinical and pre-clinical pipeline of novel biologics is balanced between internal programs, focused on ADCs and checkpoint regulators, and externally partnered programs with key innovators in oncology such as Roche, GSK, and Zymeworks. We are seeking a motivated Sr. or Principal Scientist to join the Histopathology Lab within the Target Validation team in San Jose, CA. The role involves independently designing, troubleshooting, and executing histopathology workflows to evaluate oncology targets, and presenting findings to teams and partners. You will support target validation through IHC, IF, ISH, slide scanning, image analysis, and assay optimization, with a strong focus on IHC assay development, antibody screening, tissue processing (FFPE/FF), sectioning, and tissue-based assay implementation. Hands-on histology and oncology knowledge is required.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees